SRI-42127

SRI-42127

Identifiers
IUPAC name 3-(1H-indazol-6-yl)-N-methyl-N-(oxan-4-yl)imidazo[1,2-b]pyridazin-6-amine
CAS Number	2727872-68-4
PubChem CID	163415849
Chemical and physical data
Formula	C19H20N6O
Molar mass	348.410 g·mol−1
3D model (JSmol)	Interactive image
SMILES CN(C1CCOCC1)C2=NN3C(=NC=C3C4=CC5=C(C=C4)C=NN5)C=C2
InChI InChI=1S/C19H20N6O/c1-24(15-6-8-26-9-7-15)19-5-4-18-20-12-17(25(18)23-19)13-2-3-14-11-21-22-16(14)10-13/h2-5,10-12,15H,6-9H2,1H3,(H,21,22) Key:AEHZEVSNZUVPNR-UHFFFAOYSA-N

SRI-42127 is an experimental drug which acts to inhibit translocation of the RNA-binding HuR protein. HuR translocation promotes the production of inflammatory cytokines in glial cells, and inhibiting HuR has applications both in the treatment of some forms of cancer, and also neuropathic pain. ^{[1] [2] [3]}

See also

• CMLD-2
• KH-3

References

1. Filippova N, Yang X, Ananthan S, Calano J, Pathak V, Bratton L, et al. (April 2021). "Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors". Cancer Research. 81 (8): 2220–2233. doi:10.1158/0008-5472.CAN-20-2858. PMC   8137579 . PMID   33602784.
2. Chellappan R, Guha A, Si Y, Kwan T, Nabors LB, Filippova N, et al. (January 2022). "SRI-42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide-induced neuroinflammation". Glia. 70 (1): 155–172. doi:10.1002/glia.24094. PMC   8595840 . PMID   34533864.
3. Sorge RE, Si Y, Norian LA, Guha A, Moore GE, Nabors LB, et al. (September 2022). "Inhibition of the RNA Regulator HuR by SRI-42127 Attenuates Neuropathic Pain After Nerve Injury Through Suppression of Neuroinflammatory Responses". Neurotherapeutics. 19 (5): 1649–1661. doi:10.1007/s13311-022-01278-9. PMC   9606176 . PMID   35864415.